Feb 26 (Reuters) - AIM Vaccine Co Ltd 6660.HK:
CLINICAL TRIAL OF MRNA RESPIRATORY SYNCYTIAL- VIRUS VACCINES APPROVED BY FDA
Further company coverage: 6660.HK
((Reuters.Briefs@thomsonreuters.com;))
Feb 26 (Reuters) - AIM Vaccine Co Ltd 6660.HK:
CLINICAL TRIAL OF MRNA RESPIRATORY SYNCYTIAL- VIRUS VACCINES APPROVED BY FDA
Further company coverage: 6660.HK
((Reuters.Briefs@thomsonreuters.com;))
Comments